PL3140008T3 - Szybko działające kompozycje insuliny - Google Patents

Szybko działające kompozycje insuliny

Info

Publication number
PL3140008T3
PL3140008T3 PL15723388T PL15723388T PL3140008T3 PL 3140008 T3 PL3140008 T3 PL 3140008T3 PL 15723388 T PL15723388 T PL 15723388T PL 15723388 T PL15723388 T PL 15723388T PL 3140008 T3 PL3140008 T3 PL 3140008T3
Authority
PL
Poland
Prior art keywords
fast
acting insulin
insulin compositions
compositions
acting
Prior art date
Application number
PL15723388T
Other languages
English (en)
Inventor
Michael Edward CHRISTE
Thomas Andrew HARDY
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53189204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3140008(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL3140008T3 publication Critical patent/PL3140008T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL15723388T 2014-05-08 2015-05-04 Szybko działające kompozycje insuliny PL3140008T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461990402P 2014-05-08 2014-05-08
EP15723388.3A EP3140008B1 (en) 2014-05-08 2015-05-04 Rapid-acting insulin compositions
PCT/US2015/029010 WO2015171484A1 (en) 2014-05-08 2015-05-04 Rapid-acting insulin compositions

Publications (1)

Publication Number Publication Date
PL3140008T3 true PL3140008T3 (pl) 2019-09-30

Family

ID=53189204

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15723388T PL3140008T3 (pl) 2014-05-08 2015-05-04 Szybko działające kompozycje insuliny
PL19161129T PL3536380T3 (pl) 2014-05-08 2015-05-04 Szybko działające kompozycje insuliny

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL19161129T PL3536380T3 (pl) 2014-05-08 2015-05-04 Szybko działające kompozycje insuliny

Country Status (36)

Country Link
US (2) US9439952B2 (pl)
EP (3) EP3140008B1 (pl)
JP (1) JP6050902B2 (pl)
KR (1) KR101858890B1 (pl)
CN (1) CN106456717B (pl)
AP (1) AP2016009525A0 (pl)
AR (1) AR100155A1 (pl)
AU (1) AU2015256355B2 (pl)
BR (1) BR112016024357B1 (pl)
CA (1) CA2945188C (pl)
CL (1) CL2016002772A1 (pl)
CY (2) CY1121669T1 (pl)
DK (2) DK3536380T3 (pl)
EA (1) EA031134B1 (pl)
ES (2) ES2733639T3 (pl)
HR (2) HRP20190777T1 (pl)
HU (2) HUE055742T2 (pl)
IL (1) IL248350B (pl)
JO (1) JO3624B1 (pl)
LT (2) LT3536380T (pl)
MA (1) MA39441A1 (pl)
ME (1) ME03384B (pl)
MX (1) MX367521B (pl)
NZ (1) NZ724919A (pl)
PE (1) PE20161408A1 (pl)
PH (1) PH12016502195A1 (pl)
PL (2) PL3140008T3 (pl)
PT (2) PT3140008T (pl)
RS (2) RS58726B1 (pl)
SG (1) SG11201608424WA (pl)
SI (2) SI3140008T1 (pl)
TN (1) TN2016000443A1 (pl)
TR (1) TR201906843T4 (pl)
TW (1) TWI685348B (pl)
UA (1) UA124919C2 (pl)
WO (1) WO2015171484A1 (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
EP2919804B1 (fr) 2012-11-13 2018-01-31 Adocia Formulation à action rapide d'insuline comprenant un composé anionique substitué
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
US20180221385A1 (en) * 2015-07-28 2018-08-09 Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et A pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin
JO3749B1 (ar) * 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
IL260823B2 (en) * 2016-01-29 2024-08-01 Mannkind Corp Dry powder inhaler
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations
WO2018058124A1 (en) 2016-09-26 2018-03-29 United Therapeutics Corporation Treprostinil prodrugs
EP4265296A3 (en) 2016-09-29 2023-12-20 Arecor Limited Pharmaceutical formulation comprising an insulin compound
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina
GB201707187D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
GB201707189D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
GB201707188D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
CA3065308C (en) * 2017-06-01 2022-05-17 Eli Lilly And Company Rapid-acting insulin compositions
JP7465813B2 (ja) 2018-04-04 2024-04-11 アレコル リミテッド インスリン化合物の送達のための医療用注入ポンプシステム
EP3773474B1 (en) 2018-04-04 2026-01-07 Arecor Limited Medical infusion pump system for the delivery of an insulin compound
EP3773473B1 (en) 2018-04-04 2026-07-01 Arecor Limited MEDICAL INFUSION PUMP SYSTEM FOR ADMINISTRATING AN INSULIN COMPOUND
FR3083985A1 (fr) 2018-07-23 2020-01-24 Adocia Dispositif pour injecter une solution d'insuline(s)
WO2019243627A1 (fr) 2018-06-23 2019-12-26 Adocia Dispositif pour injecter une solution d'insuline(s)
CN112739679B (zh) 2018-09-18 2024-03-12 伊莱利利公司 曲前列环素的特丁胺盐
US10799564B1 (en) * 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same
CN114096269B (zh) * 2019-07-12 2024-06-11 诺和诺德股份有限公司 高浓度胰岛素制剂
CN114616225A (zh) 2019-08-23 2022-06-10 联合治疗公司 曲前列环素前药
GB202004814D0 (en) 2020-04-01 2020-05-13 Arecor Ltd Novel formulations
IL296567A (en) 2020-04-17 2022-11-01 United Therapeutics Corp Terfostinil for use in the treatment of interstitial lung disease
AU2021289336B2 (en) 2020-06-09 2025-08-28 Mannkind Corporation Fumaryl diketopiperidine prodrugs of treprostinil
CN115697379A (zh) * 2020-06-30 2023-02-03 江苏恒瑞医药股份有限公司 速效胰岛素组合物及其医药用途
KR102849520B1 (ko) 2020-12-14 2025-08-25 유나이티드 쎄러퓨틱스 코포레이션 트레프로스티닐 프로드러그로 질환을 치료하는 방법
WO2022187352A1 (en) 2021-03-03 2022-09-09 United Therapeutics Corporation A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp)
EP4516297A4 (en) * 2022-04-29 2026-02-25 Zhaoke pharmaceutical guangzhou co ltd Treprostinil Gentle Inhalation Mist
US20240067957A1 (en) * 2022-08-22 2024-02-29 Massachusetts Institute Of Technology Autocatalytic base editing for rna-responsive translational control

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740953A1 (de) 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
JPH10251146A (ja) * 1997-03-11 1998-09-22 Toray Ind Inc 糖尿病性神経障害の治療方法
WO2003020201A2 (en) * 2001-08-28 2003-03-13 Eli Lilly And Company Pre-mixes of glp-1 and basal insulin
WO2003094956A1 (en) * 2002-05-07 2003-11-20 Novo Nordisk A/S Soluble formulations comprising monomeric insulin and acylated insulin
DE602005020269D1 (de) * 2004-04-12 2010-05-12 United Therapeutics Corp Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
CA2697057A1 (en) * 2007-08-22 2009-02-26 Gilead Colorado, Inc. Therapy for complications of diabetes
US9387033B2 (en) 2008-08-28 2016-07-12 Roche Diabetes Care, Inc. Device and method for enhanced subcutaneous insulin absorption
EP2330893A4 (en) * 2008-09-25 2013-01-09 Aradigm Corp DEEP PULMONARY ADMINISTRATION OF TREPROSTINIL
ES2543705T3 (es) 2009-06-26 2015-08-21 Novo Nordisk A/S Preparación que contiene insulina, nicotinamida y arginina
KR101701943B1 (ko) * 2009-11-13 2017-02-02 도레이 카부시키가이샤 당뇨병의 치료 또는 예방약
KR20140030125A (ko) 2010-12-14 2014-03-11 노보 노르디스크 에이/에스 인슐린, 니코틴아미드 및 아미노산을 포함하는 제제
BR112014003225A2 (pt) * 2011-08-12 2017-03-01 Ascendis Pharma As profármacos de treprostinil ligados a veículo
US9381247B2 (en) * 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
US20150065423A1 (en) 2013-08-30 2015-03-05 Perosphere, Inc. Rapid acting injectable formulations
WO2015120457A1 (en) 2014-02-10 2015-08-13 Biodel Inc. Stabilized ultra-rapid-acting insulin formulations

Also Published As

Publication number Publication date
PT3536380T (pt) 2021-09-02
RS62291B1 (sr) 2021-09-30
TW201625291A (zh) 2016-07-16
HRP20190777T1 (hr) 2019-08-23
CY1124454T1 (el) 2022-07-22
WO2015171484A1 (en) 2015-11-12
US9439952B2 (en) 2016-09-13
EP3536380A1 (en) 2019-09-11
TR201906843T4 (tr) 2019-05-21
JO3624B1 (ar) 2020-08-27
EA201691911A1 (ru) 2017-02-28
PT3140008T (pt) 2019-06-25
HUE055742T2 (hu) 2021-12-28
TN2016000443A1 (en) 2018-04-04
EP3536380B8 (en) 2021-09-22
RS58726B1 (sr) 2019-06-28
SI3536380T1 (sl) 2021-09-30
ES2733639T3 (es) 2019-12-02
PL3536380T3 (pl) 2021-12-27
CY1121669T1 (el) 2020-07-31
AR100155A1 (es) 2016-09-14
TWI685348B (zh) 2020-02-21
LT3536380T (lt) 2021-08-10
SG11201608424WA (en) 2016-11-29
IL248350B (en) 2020-03-31
DK3536380T3 (da) 2021-08-02
US20160129087A1 (en) 2016-05-12
JP6050902B2 (ja) 2016-12-21
AP2016009525A0 (en) 2016-10-31
SI3140008T1 (sl) 2019-06-28
AU2015256355A1 (en) 2016-10-27
PH12016502195B1 (en) 2017-02-06
US20160367640A1 (en) 2016-12-22
KR101858890B1 (ko) 2018-05-16
NZ724919A (en) 2018-01-26
MA39441A1 (fr) 2017-06-30
CN106456717A (zh) 2017-02-22
EP3536380B1 (en) 2021-07-07
EA031134B1 (ru) 2018-11-30
MX2016014643A (es) 2017-03-06
KR20160133567A (ko) 2016-11-22
ES2891983T3 (es) 2022-02-01
DK3140008T3 (da) 2019-06-24
IL248350A0 (en) 2016-11-30
AU2015256355B2 (en) 2017-09-14
CA2945188A1 (en) 2015-11-12
PH12016502195A1 (en) 2017-02-06
EP3140008A1 (en) 2017-03-15
BR112016024357A2 (pt) 2017-10-10
HRP20211415T1 (hr) 2021-12-10
LT3140008T (lt) 2019-05-27
CA2945188C (en) 2018-12-11
CL2016002772A1 (es) 2017-06-09
PE20161408A1 (es) 2016-12-28
EP3140008B1 (en) 2019-04-17
UA124919C2 (uk) 2021-12-15
CN106456717B (zh) 2020-01-17
BR112016024357B1 (pt) 2022-08-23
US10172922B2 (en) 2019-01-08
EP3943155A1 (en) 2022-01-26
HUE044370T2 (hu) 2019-10-28
JP2016523807A (ja) 2016-08-12
MX367521B (es) 2019-08-26
ME03384B (me) 2020-01-20

Similar Documents

Publication Publication Date Title
DK3536380T3 (da) Hurtigtvirkende insulinsammensætninger
DK3233108T3 (da) Hurtigtvirkende insulinsammensætninger
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3542812T3 (da) Glycopeptidsammensætninger
LT3240415T (lt) Fungicidinės kompozicijos
PT3340966T (pt) Composições de insulina de ação rápida
EP3339331A4 (en) COMPOSITION
EP3398996A4 (en) COMPOSITION
FR3024363B1 (fr) Composition thermogelifiable
BR112017001922A2 (pt) composições fungicidas
DK3250182T3 (da) Dispergible sammensætninger
DK3334726T3 (da) Plinabulinsammensætninger
CL2017000639A1 (es) Composición
EA202092926A3 (ru) Лиофилизированные составы, содержащие фактор ix
EP3395887C0 (en) FLUOROR RUBBER COMPOSITION
DK3322295T3 (da) Sammensætning
DK3397734T3 (da) Brændstofsammensætning
DK3316857T3 (da) Multifasiske sammensætninger
DK3393254T3 (da) Sammensætning
LT3173071T (lt) Maropitanto kompozicija
EP3369418A4 (en) COMPOSITION
HUE070090T2 (hu) Összetétel
IL251479B (en) Compositions
EP3315031A4 (en) COMPOSITION
HUE055715T2 (hu) Táp kompozíció